Injecting a syringe of an unapproved treatment into a patient’s eyeball would be a nightmare scenario for most ophthalmologists. But that is what many major insurance companies are now suggesting doctors do. Learn more.
By Susan Barajas When you have a disease nobody has heard of, it’s easy to feel alone. And when insurance companies make it harder for you to access treatment, it can become even more disheartening. I know these feelings all too well. Read More
With the nation’s attention riveted on the distribution of COVID-19 vaccines, drugs that allow patients to deal with other serious medical conditions are falling by the wayside. But it doesn’t need to be that way. The Coronavirus Aid, Relief and Economic Security Act of 2020 gave the Food and Drug Administration the power to prevent and mitigate drug shortages without affecting the rollout of COVID-19
From work to school, book clubs to coffee dates, people are online more than ever before. And eye care professionals are bracing for the inevitable impact on vision health. Vision strain caused by a spike in screen time could introduce a number of issues for patients. In many cases, the problem may be made worse by delays in routine care. This combination of
The disease most likely to lead to blindness remains largely unknown to most Americans, a recent study shows. Diabetic retinopathy, which affects more than 8 million Americans, damages the blood vessels in the retina, causing blurred vision, floaters and, in late stages, retinal detachment. The disease is projected to become even more common. Yet most adults are unfamiliar with its risk factors and symptoms, which include
A new study predicts an alarming increase in global vision impairment. The review of more than 500 studies found that the number of people who experience blindness and vision loss is likely to double by 2050. The finding suggests that advancements related to eye health may not be keeping pace with need. Read More.
More than 2 billion people globally have a vision impairment – nearly half of which could have been prevented or have yet to be addressed. That’s why World Sight Day, an international day of awareness held each October, focuses attention on the important global issue of eye health. World Sight Day provides a platform for organizations to encourage governments, corporations, institutions and individuals
How can policymakers keep care accessible for seniors with a debilitating vision condition called thyroid eye disease? By allowing for infused treatment at home, suggests a new survey of Medicare beneficiaries. As reported by the Vision Health Advocacy Coalition, home infusion could allow people to access thyroid eye disease treatment without risking exposure to the coronavirus or other infectious diseases, such as the
What do cataract, dry eye, glaucoma and age-related macular degeneration have in common? They’re more prevalent in women. In fact, vision and eye conditions across the board disproportionately affect women. That’s why April serves as Women’s Eye Health and Safety Month, giving patients and advocates an opportunity to raise awareness, increase public education and urge women to prioritize their vision health. Women face
The verdict is in: personalized, patient-centered care is better care. That’s especially true when it comes to dry eye disease. A recent review published in The Journal of Clinical Medicine explores emerging areas of dry eye research that could benefit patients. New progress sparks hope for more treatment options that would support patient-centered dry eye care. Dry eye disease occurs when the eyes can’t produce